Cecilia Smith S.
- Country
- Norway
- Department
- Department of Neurology,
Research Overview
Data & Insights
Has run more than one trial at 3 of 17 partner sites.
Specializations
Oncology – Solid Tumors
Advances in targeted and immunotherapy approaches for major solid cancers.
- non‑small cell lung cancer
- breast cancer
- melanoma
- pancreatic adenocarcinoma
- small cell lung cancer
Emphasis on molecular subtyping and combination regimens to improve survival.
Neurology – Neurodegenerative Disorders
Investigation of disease‑modifying and symptomatic therapies for progressive neurological conditions.
- multiple sclerosis
- amyotrophic lateral sclerosis
- acute ischemic stroke
- neuropathic pain management
Focus on neuroprotection, immune modulation, and functional recovery.
Cardiovascular & Metabolic Health
Therapeutic development for atherosclerotic disease and metabolic risk factors.
- atherosclerotic cardiovascular disease
- chronic heart failure
- type 2 diabetes
- obesity
- hypertension
Projects address cardiovascular outcomes, renal protection, and lipid management.
Immunology & Gastroenterology
Targeted interventions for immune‑mediated inflammatory diseases.
- crohn's disease
- juvenile idiopathic arthritis
- ulcerative colitis
- immune‑mediated gastrointestinal disorders
Efforts include biologic agents, small‑molecule inhibitors, and combination strategies.
Infectious Diseases & Critical Care
Evaluation of antiviral, antibacterial, and supportive therapies for acute infections and sepsis.
- covid‑19
- viral respiratory tract infection
- sepsis
- antibiotic stewardship in critical care
Studies aim to improve outcomes through optimized antimicrobial regimens and host‑response modulation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
